LiveWire   Ergogenics   Retains   Experts   to   Assist Company  
in   Obtaining   Cannabis   Licenses   and   Permits
Anaheim,   CA     February   21,   2018     LiveWire   Ergogenics,   Inc.   (OTC:   LVVV),
which   focuses   on   research   partnerships,   product   development,   acquisition,   and
management   of   turnkey   production   facilities   for   cannabis-based   products   and
services,   has   retained   the   services   of   the   Law   Offices   of   Omar   Figueroa   as   well   as
development   firm   Cushman   Greenfield.   Both   companies   will   be   working   together   to
assist   LiveWire   in   identifying   and   obtaining   licenses,   permits   and   other
authorizations   required   by   various   California   state   and   local   governments   to   allow
LiveWire   to   engage   in   cannabis   activities   permitted   by   California   state   law.

A   pioneering   cannabis   lawyer,   Omar   Figueroa   is   also   the   author   of   “Cannabis   Codes
of   California,”   the   first   comprehensive   guide   to   the   laws   and   regulations   that   govern
the   California   cannabis   industry.   Known   for   his   ability   to   think   outside   the   box   and
solve   complex   problems   in   novel   ways,   Mr.   Figueroa   will   be   working   with   LiveWire
Ergogenics   in   the   areas   of   permitting,   licensing   and   regulatory   compliance;
business   law;   intellectual   property;   and   legal   education.

Cushman   Greenfield   is   a   well-regarded   development   firm   specializing   in   license
application   and   procurement   in   the   medical   cannabis   industry.   In   addition   to
helping   LiveWire   navigate   various   license   applications,   they   will   also   be   providing
expert   advice   in   the   areas   of   business   development,   brand   development   and
government   affairs.

“We   have   chosen   to   work   with   Omar   Figueroa   and   Cushman   Greenfield   because
these   are   two   of   the   top   organizations   in   their   fields,”   states   Bill   Hodson,   LiveWire’s
CEO.   “Their   expertise   will   be   a   significant   asset   to   us   both   immediately   and   as   our
business   grows.   This   is   another   valuable   addition   to   our   team.”

For   more   information   about   LiveWire   Ergogenics,   visit .   For   non-material   updates,   follow   LiveWire
Ergogenics   on   Twitter   @livewireLVVV.

About   LiveWire   Ergogenics,   Inc.
LiveWire   Ergogenics,   Inc.   (LVVV)   specializes   in   identifying   and   monetizing   current
and   future   trends   in   the   health   and   wellness   industry.   The   Company   is   currently
focused   on   establishing   research   partnerships   to   explore   the   application   of
cannabinoid-based   products   to   target   specific   ailments   or   conditions   with   large
“sufferer”   populations   for   human   and   veterinarian   applications.   This   includes   the
cloning   of   cannabis   strains   to   produce   positive   medicinal   results,   dosing   verification
of   zero   pesticide   products   for   quality   brands,   and   development   and   licensing   of
high-quality   cannabinoid-based   products   and   services.   The   team   at   LiveWire
Ergogenics   has   a   passion   for   research   and   is   committed   to   generating   and
implementing   innovative   ideas   and   producing   high-quality   products   that   satisfy   an
increasing   demand   in   this   fast-growing   industry.

Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts
may constitute forward-looking statements. Forward-looking statements may
include, without limitation, financial projections, statements regarding the plans
and objectives of management for future operations, the development, regulatory
approvals and commercialization of the Company’s products, or any of the
Company’s other proposed products, systems or services.

Such forward-looking statements are not meant to predict or guarantee actual
results, performance, events or circumstances and actual events may differ
considerably. Factors that may cause actual results to differ materially from any
projections may include, without limitation, the Company’s inability to obtain
additional financing, delays in the development of its products, the impact of
significant government regulation in the cannabis industry, existing or increased
competition, results of arbitration and litigation, stock volatility and illiquidity, and
the Company’s failure to implement the Company’s business plans or strategies.
The Company assumes no obligation to update any forward-looking statements to
reflect any event or circumstance that may arise after the date of this release.

EquiNet,   LLC
Toll   free:   877-964-6463
Direct:   858-264-6500

1600   North   Kraemer   Blvd.
Anaheim,   CA   92806
We initiated coverage of LiveWire Ergogenics on August 16, 2017
If you want to follow all other companies that we cover with more in depth research reports, go to our research site at to download the reports,
or visit for up to date news on the covered companies.
Please feel free to re-distribute the reports to your friends and colleagues.
StockWatchIndex and SWI Research (SWI) are not registered investment advisers and the information provided herein or any other SWI publication is not to be construed as personal financial advice, or a solicitation to buy or sell stock. SWI makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in its publications or on its web sites. Some of the published information has been provided by the companies covered, generated by publicly available sources, or what SWI deems to be reliable third party entities, but SWI does not guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or warrant any results from use of the information. Readers are encouraged to consult their personal financial adviser before making any decisions to buy, sell or hold any securities mentioned herein. StockWatchIndex is not responsible for any error, mistake or shortcoming that may be occasioned at the time of publishing of the information in this publication, any other SWI publication, or its web sites and is not obligated to update and/or correct information. No liability is accepted by StockWatchIndex whatsoever for any direct, indirect or consequential loss arising from the use of the information. SWI expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information provided. SWI has been compensated with five million restricted shares (subject to the restrictions of rule 144) by the Company  for the dissemination of this and future releases and  for continuing consulting and advisory services. The included information is subject to change without notice. Please visit!legal-ease/lmvw1   for a full text of our Disclaimer, Privacy policy and Terms of Use.